Public Profile

HPGC Renmintongtai Pharmaceutical Corporation

HPGC Renmintongtai Pharmaceutical Corporation, headquartered in China (CN), is a prominent player in the pharmaceutical industry, specialising in the research, development, and manufacturing of innovative healthcare solutions. Founded in the early 2000s, the company has achieved significant milestones, establishing a strong presence in both domestic and international markets. With a focus on traditional Chinese medicine and modern pharmaceutical products, HPGC Renmintongtai offers a diverse range of core services, including herbal formulations and advanced therapeutic agents. Their commitment to quality and efficacy sets them apart in a competitive landscape. Recognised for their contributions to healthcare, the corporation has garnered a reputation for excellence, positioning itself as a leader in the industry.

DitchCarbon Score

How does HPGC Renmintongtai Pharmaceutical Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

10

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

14

Industry Benchmark

HPGC Renmintongtai Pharmaceutical Corporation's score of 10 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.

11%

HPGC Renmintongtai Pharmaceutical Corporation's reported carbon emissions

HPGC Renmintongtai Pharmaceutical Corporation, headquartered in China, currently does not have available data on its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. This lack of information suggests that HPGC Renmintongtai may still be in the early stages of developing a comprehensive climate strategy or reporting framework. In the pharmaceutical industry, companies are increasingly recognising the importance of addressing carbon emissions and setting ambitious targets to mitigate climate impact. As such, HPGC Renmintongtai may benefit from establishing clear commitments and measurable goals to enhance its sustainability profile and align with industry standards.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. HPGC Renmintongtai Pharmaceutical Corporation's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. HPGC Renmintongtai Pharmaceutical Corporation is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

HPGC Renmintongtai Pharmaceutical Corporation is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Was this information valuable to you?

Similar Organizations

China Health Industries Holdings, Inc.

CN
Chemicals nec
Updated about 1 month ago

YeeCare.com

CN
Updated about 1 month ago

Unisplendour Corporation Limited

CN
Computer and related services (72)
Updated about 1 month ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers